CGVHD 2024

#CGVHD2024

SAVE UP TO $150

Early Bird Registration

Now Open!

Chronic GvHD is a Global Disease

Early Registration

Prepare yourself to learn about the latest developments in the field of Graft-versus-Host Disease and connect with experts. 

Call for Abstracts

Contribute to the progress of Chronic Graft-versus-Host Disease research by submitting your abstract.

Congress Program

Explore key sessions, top speakers, and the latest research in the Chronic Graft-versus-Host Disease field.

Important Dates

March 25
Early Registration Opens
May 16
Abstract Submission Opens
August 5
Abstract Submission Deadline
August 16
Abstract Notifications
August 15
Early Registration Deadline
September 29
Accommodation Booking Deadline
October 9
Registration Deadline

Why Attend cGvHD 2024?

NETWORKING OPPORTUNITIES

The congress provides a unique platform for professionals, researchers, and patients in the field of chronic Graft-versus-Host Disease to come together to network and learn from each other. It allows attendees to connect and establish valuable relationships with like-minded individuals.

STATE-OF-THE-ART RESEARCH

cGvHD 2024 showcases the latest advancements in research, scientific breakthroughs, and innovative approaches related to chronic Graft-versus-Host Disease.

PROFESSIONAL DEVELOPMENT

Participating in the congress contributes to your professional development. Seize the opportunity to learn about the latest evidence-based practices, refine your skills and stay informed about the current guidelines and gain insights into emerging trends.

INTERNATIONAL PERSPECTIVE

The congress brings together a global community, attracting participants from various countries and cultures. This diversity creates an exchange of ideas and perspectives that can broaden your horizon by gaining insights into chronic Graft-versus-Host Disease from an international standpoint.

Abstracts Submissions Will Close In

0Days
/
0Hours
/
0Minutes
/
0Seconds

Hosted by Cell Therapy Transplant Canada

With Partner KroHem (The Croatian Cooperative Group for Hematologic Diseases)